J. Näsman

发表

Adrenoceptor activity of muscarinic toxins identified from mamba venoms

J. Meriluoto, J. Kukkonen, D. Toivola, 2011, British journal of pharmacology.

Selective targeting of G‐protein‐coupled receptor subtypes with venom peptides

K. Näreoja, J. Näsman, J. Näsman, 2012, Acta physiologica.

Comparison of the baculovirus‐insect cell and Pichia pastoris heterologous systems for the expression of the human tumor suppressor protein RNASET2

A. Dell, Ivan Raimondi, P. Campomenosi, 2011, Biotechnology and applied biochemistry.

Enhancement of agonist binding to 5-HT1A receptors in rat brain membranes by millimolar Mn2+

A. Rinken, J. Näsman, S. Parkel, 2009, Neuroscience Letters.

Canonical Transient Receptor Potential Channel 2 (TRPC2) as a Major Regulator of Calcium Homeostasis in Rat Thyroid FRTL-5 Cells

P. Sukumaran, P. Kankaanpää, J. Näsman, 2012, The Journal of Biological Chemistry.

Different roles for Gi and Go proteins in modulation of adenylyl cyclase type‐2 activity

J. Kukkonen, K. Åkerman, J. Näsman, 2002, Journal of neurochemistry.

Protean Agonism at a 2A -Adrenoceptors

J. Näsman, S. Wurster, J. Savola, 1998 .

Protean Agonism at a 2 A-Adrenoceptors

K. Åkerman, J. Näsman, S. Wurster, 1998 .

Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction

Pauli M Turunen, R. Ra, J. Kukkonen, 2011, FEBS letters.

The Orexin OX1 Receptor Regulates Ca2+ Entry via Diacylglycerol-Activated Channels in Differentiated Neuroblastoma Cells

K. Larsson, K. Åkerman, J. Näsman, 2006, The Journal of Neuroscience.

Enhanced early expression of membrane receptors with the Rous sarcoma virus promoter in baculovirus‐infected insect cells

K. Åkerman, K. Näreoja, J. Näsman, 2012, Biotechnology and applied biochemistry.

Glycosylphosphatidylinositol (GPI)-anchoring of mamba toxins enables cell-restricted receptor silencing.

J. Meriluoto, K. Åkerman, K. Näreoja, 2012, Biochemical and biophysical research communications.

Molecular Conversion of Muscarinic Acetylcholine Receptor M5 to Muscarinic Toxin 7 (MT7)-Binding Protein

K. Näreoja, S. Rondinelli, J. Näsman, 2011, Toxins.

Characterization of M2 muscarinic receptor activation of different G protein subtypes

A. Rinken, K. Åkerman, J. Näsman, 2004, Neurochemistry International.

Agonist channeling of α2-adrenoceptor function

J. Kukkonen, K. Åkerman, J. Näsman, 2002 .

Alpha2B-adrenoceptors couple to Ca2+ increase in both endogenous and recombinant expression systems.

C. Holmberg, J. Kukkonen, M. Courtney, 1998, European journal of pharmacology.

Endogenous extracellular purine nucleotides redirect α2‐adrenoceptor signaling

P. Lund, J. Kukkonen, K. Åkerman, 1998 .

Recombinant expression of a selective blocker of M(1) muscarinic receptors.

K. Åkerman, J. Näsman, E. Karlsson, 2000, Biochemical and biophysical research communications.

The three-finger toxin MTalpha is a selective alpha(2B)-adrenoceptor antagonist.

S. Rondinelli, J. Näsman, Katja Koivula, 2010, Toxicon : official journal of the International Society on Toxinology.

Endogenous extracellular purine nucleotides redirect alpha2-adrenoceptor signaling.

P. Lund, J. Kukkonen, K. Åkerman, 1998, FEBS letters.

Alpha2 adrenergic receptor activation and intracellular Ca2

C. Holmberg, J. Kukkonen, M. Courtney, 1997 .

Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression system.

J. Kukkonen, K. Åkerman, J. Näsman, 1996, The Journal of pharmacology and experimental therapeutics.

Autocrine Endocannabinoid Signaling through CB1 Receptors Potentiates OX1 Orexin Receptor Signaling

Pauli M Turunen, C. Lindqvist, J. Kukkonen, 2013, Molecular Pharmacology.

Alpha-2 Adrenergic Receptors and Signal Transduction: Effector Output in Relation to G-Protein Coupling and Signalling Cross-Talk

J. Näsman, J. Näsman, 2002 .

Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer.

M. Santoro, F. Basolo, J. Dumont, 2010, Endocrine-related cancer.

Role of third intracellular loop of galanin receptor type 1 in signal transduction

Ü. Langel, A. Valkna, K. Åkerman, 2000, Neuropeptides.

New Strategies for Expression and Purification of Recombinant Human RNASET2 Protein in Pichia pastoris

F. Acquati, R. Taramelli, C. Lindqvist, 2015, Molecular Biotechnology.

Muscarinic receptor subtypes in human neuroblastoma cell lines SH-SY5Y and IMR-32 as determined by receptor binding, Ca++ mobilization and northern blotting.

J. Kukkonen, K. Åkerman, J. Näsman, 1992, The Journal of pharmacology and experimental therapeutics.

Muscarinic Toxin 7 Selectivity Is Dictated by Extracellular Receptor Loops*

K. Åkerman, M. Peräkylä, J. Näsman, 2004, Journal of Biological Chemistry.

The STC-1 cells express functional orexin-A receptors coupled to CCK release.

K. Herzig, J. Kukkonen, K. Larsson, 2003, Biochemical and biophysical research communications.

Pseudo-noncompetitive antagonism of M1, M3, and M5 muscarinic receptor-mediated Ca2+ mobilization by muscarinic antagonists.

J. Kukkonen, A. Rinken, K. Åkerman, 1998, Biochemical and biophysical research communications.

Two human α2-adrenoceptor subtypes α2A-C10 and α2B-C2 expressed in Sf9 cells couple to transduction pathway resulting in opposite effects on cAMP production

M. Karp, K. Åkerman, J. Näsman, 1995 .

The Second Intracellular Loop of the α2-Adrenergic Receptors Determines Subtype-specific Coupling to cAMP Production*

K. Åkerman, J. Näsman, C. Jansson, 1997, The Journal of Biological Chemistry.

Modelling of promiscuous receptor-Gi/Gs-protein coupling and effector response.

J. Kukkonen, K. Åkerman, K E Akerman, 2001, Trends in pharmacological sciences.

Differentiation dependent expression of TRPA1 and TRPM8 channels in IMR‐32 human neuroblastoma cells

T. Nordström, K. Larsson, J. Näsman, 2009, Journal of cellular physiology.

[3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine.

J. Wikberg, H. Schiöth, M. Dambrova, 1998, European journal of pharmacology.

Protean agonism at alpha2A-adrenoceptors.

J. Kukkonen, K. Åkerman, K E Akerman, 1998, Molecular pharmacology.

Agonist potency differentiates G protein activation and Ca2+ signalling by the orexin receptor type 1.

J. Kukkonen, K. Åkerman, J. Näsman, 2006, Biochemical pharmacology.

Dual signalling by different octopamine receptors converges on adenylate cyclase in Sf9 cells.

J. Kukkonen, K. Åkerman, J. Näsman, 2002, Insect biochemistry and molecular biology.

Selective interference with TRPC3/6 channels disrupts OX1 receptor signalling via NCX and reveals a distinct calcium influx pathway.

T. Nordström, K. Åkerman, J. Näsman, 2010, Cell calcium.